Bartushak Jaime Insider Trades

Insider Trading History

Track insider trading activity for Bartushak Jaime. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Citius Oncology
Citius Oncology CTOR
Chief Financial Officer
Holding Value $657k 825,000 shares
Last Trade
Sep 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.45M 825,000 shares
$1.76
$0.80
Citius Oncology
Citius Oncology CTOR
Chief Financial Officer
Holding Value $318k 400,000 shares
Last Trade
Dec 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$428k 400,000 shares
$1.07
$0.80
Citius Pharmaceuticals
Citius Pharmaceuticals CTXR
Chief Financial Officer
Holding Value $206k 350,000 shares
Last Trade
Nov 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.35M 350,000 shares
$9.56
$0.59
Citius Pharmaceuticals- Warrants(02/08/2022)
Citius Pharmaceuticals- Warrants(02/08/2022) CTXRW
Chief Financial Officer
Holding Value $50.4k 350,000 shares
Last Trade
Nov 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$50.4k 350,000 shares
$0.14
$0.14
Citius Oncology
Citius Oncology CTOR
Chief Financial Officer
Holding Value $371k 466,667 shares
Last Trade
Aug 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.80
Citius Oncology
Citius Oncology CTOR
Chief Financial Officer
Holding Value $1.11M 1,400,000 shares
Last Trade
Aug 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.80
Citius Pharmaceuticals- Warrants(02/08/2022)
Citius Pharmaceuticals- Warrants(02/08/2022) CTXRW
Chief Financial Officer
Holding Value $43.2k 300,000 shares
Last Trade
Oct 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.2k 300,000 shares
$0.14
$0.14
Citius Pharmaceuticals
Citius Pharmaceuticals CTXR
Chief Financial Officer
Holding Value $177k 300,000 shares
Last Trade
Oct 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.25M 300,000 shares
$17.50
$0.59
Citius Pharmaceuticals
Citius Pharmaceuticals CTXR
Chief Financial Officer
Holding Value $177k 300,000 shares
Last Trade
Oct 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.38M 300,000 shares
$31.25
$0.59
Citius Pharmaceuticals- Warrants(02/08/2022)
Citius Pharmaceuticals- Warrants(02/08/2022) CTXRW
Chief Financial Officer
Holding Value $43.2k 300,000 shares
Last Trade
Oct 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.2k 300,000 shares
$0.14
$0.14
Citius Pharmaceuticals- Warrants(02/08/2022)
Citius Pharmaceuticals- Warrants(02/08/2022) CTXRW
Chief Financial Officer
Holding Value $43.2k 300,000 shares
Last Trade
Oct 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$204k 300,000 shares
$0.68
$0.14
Citius Pharmaceuticals
Citius Pharmaceuticals CTXR
Chief Financial Officer
Holding Value $177k 300,000 shares
Last Trade
Oct 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.3M 300,000 shares
$51.00
$0.59
Citius Pharmaceuticals- Warrants(02/08/2022)
Citius Pharmaceuticals- Warrants(02/08/2022) CTXRW
Chief Financial Officer
Holding Value $14.4k 100,000 shares
Last Trade
Jul 22, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$90k 100,000 shares
$0.90
$0.14
Citius Pharmaceuticals
Citius Pharmaceuticals CTXR
Chief Financial Officer
Holding Value $59k 100,000 shares
Last Trade
Jul 22, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5M 100,000 shares
$50.00
$0.59
Citius Pharmaceuticals
Citius Pharmaceuticals CTXR
Chief Financial Officer
Holding Value $73.7k 125,000 shares
Last Trade
Oct 06, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.16M 125,000 shares
$25.25
$0.59
Citius Pharmaceuticals- Warrants(02/08/2022)
Citius Pharmaceuticals- Warrants(02/08/2022) CTXRW
Chief Financial Officer
Holding Value $18k 125,000 shares
Last Trade
Oct 06, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.8k 125,000 shares
$0.35
$0.14
Citius Pharmaceuticals- Warrants(02/08/2022)
Citius Pharmaceuticals- Warrants(02/08/2022) CTXRW
Chief Financial Officer
Holding Value $14.4k 100,000 shares
Last Trade
Oct 08, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14k 100,000 shares
$0.14
$0.14
Citius Pharmaceuticals
Citius Pharmaceuticals CTXR
Chief Financial Officer
Holding Value $59k 100,000 shares
Last Trade
Oct 08, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.68M 100,000 shares
$16.75
$0.59
Citius Pharmaceuticals- Warrants(02/08/2022)
Citius Pharmaceuticals- Warrants(02/08/2022) CTXRW
Chief Financial Officer
Holding Value $10.1k 70,000 shares
Last Trade
Sep 04, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.2k 70,000 shares
$0.26
$0.14
Citius Pharmaceuticals
Citius Pharmaceuticals CTXR
Chief Financial Officer
Holding Value $41.3k 70,000 shares
Last Trade
Sep 04, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.84M 70,000 shares
$40.50
$0.59

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up